Walleye Trading’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-2,200
| Closed | -$27.2K | – | 4387 |
|
|
2025
Q3 | $27.2K | Buy |
+2,200
| New | +$25.8K | ﹤0.01% | 4085 |
|
|
2023
Q2 | – | Sell |
-4,500
| Closed | -$99.2K | – | 4738 |
|
|
2023
Q1 | $99.2K | Buy |
+4,500
| New | +$105K | ﹤0.01% | 3860 |
|
|
2021
Q4 | – | Sell |
-16,200
| Closed | -$450K | – | 5399 |
|
|
2021
Q3 | $450K | Sell |
16,200
-12,300
| -43% | -$374K | ﹤0.01% | 3017 |
|
|
2021
Q2 | $1.11M | Buy |
28,500
+18,300
| +179% | +$656K | ﹤0.01% | 2030 |
|
|
2021
Q1 | $294K | Hold |
10,200
| – | – | ﹤0.01% | 3240 |
|
|
2020
Q4 | $270K | Buy |
+10,200
| New | +$208K | ﹤0.01% | 3246 |
|
|
2020
Q3 | – | Sell |
-19,900
| Closed | -$404K | – | 4161 |
|
|
2020
Q2 | $404K | Buy |
19,900
+15,400
| +342% | +$276K | ﹤0.01% | 2444 |
|
|
2020
Q1 | $47K | Buy |
4,500
+2,500
| +125% | +$69.9K | ﹤0.01% | 3437 |
|
|
2019
Q4 | $75K | Sell |
2,000
-5,700
| -74% | -$256K | ﹤0.01% | 3674 |
|
|
2019
Q3 | $359K | Buy |
7,700
+6,500
| +542% | +$302K | ﹤0.01% | 2436 |
|
|
2019
Q2 | $63K | Sell |
1,200
-1,200
| -50% | -$70.4K | ﹤0.01% | 3465 |
|
|
2019
Q1 | $165K | Buy |
2,400
+1,500
| +167% | +$101K | ﹤0.01% | 3165 |
|
|
2018
Q4 | $54K | Sell |
900
-13,000
| -94% | -$1.12M | ﹤0.01% | 4112 |
|
|
2018
Q3 | $1.61M | Buy |
13,900
+10,800
| +348% | +$1.22M | 0.01% | 1574 |
|
|
2018
Q2 | $391K | Buy |
3,100
+2,600
| +520% | +$316K | ﹤0.01% | 3063 |
|
|
2018
Q1 | $54K | Sell |
500
-4,800
| -91% | -$531K | ﹤0.01% | 4113 |
|
|
2017
Q4 | $581 | Sell |
5,300
-3,800
| -42% | -$379K | ﹤0.01% | 2472 |
|
|
2017
Q3 | $900 | Buy |
9,100
+8,600
| +1,720% | +$834K | ﹤0.01% | 1962 |
|
|
2017
Q2 | $51 | Sell |
500
-2,800
| -85% | -$302K | ﹤0.01% | 3878 |
|
|
2017
Q1 | $383 | Buy |
3,300
+1,300
| +65% | +$151K | ﹤0.01% | 2466 |
|
|
2016
Q4 | $240K | Sell |
2,000
-3,100
| -61% | -$343K | ﹤0.01% | 2658 |
|
|
2016
Q3 | $571K | Sell |
5,100
-300
| -6% | -$34.6K | ﹤0.01% | 2024 |
|
|
2016
Q2 | $669K | Sell |
5,400
-4,200
| -44% | -$507K | ﹤0.01% | 1944 |
|
|
2016
Q1 | $1.08M | Sell |
9,600
-17,000
| -64% | -$1.77M | 0.01% | 1330 |
|
|
2015
Q4 | $2.89M | Buy |
26,600
+24,600
| +1,230% | +$2.82M | 0.03% | 581 |
|
|
2015
Q3 | $200K | Sell |
2,000
-5,700
| -74% | -$620K | ﹤0.01% | 2357 |
|
|
2015
Q2 | $878K | Buy |
7,700
+2,800
| +57% | +$340K | 0.01% | 1211 |
|
|
2015
Q1 | $510K | Buy |
4,900
+2,100
| +75% | +$224K | 0.01% | 1471 |
|
|
2014
Q4 | $337K | Sell |
2,800
-6,300
| -69% | -$828K | ﹤0.01% | 1905 |
|
|
2014
Q3 | $1.33M | Buy |
9,100
+5,900
| +184% | +$911K | 0.02% | 659 |
|
|
2014
Q2 | $536 | Buy |
3,200
+500
| +19% | +$89K | 0.01% | 1216 |
|
|
2014
Q1 | $536 | Buy |
2,700
+2,000
| +286% | +$378K | 0.01% | 1246 |
|
|
2013
Q4 | $133K | Buy |
+700
| New | +$130K | ﹤0.01% | 2373 |
|
Other funds holding CLB
AI
DGI
Walleye Trading's CLB Position: Q4 2021 in Review
Walleye Trading sold out of Core Laboratories (CLB) in Q4 2021, closing a stake of 5,424 shares — an estimated $151K sold.
Walleye Trading first reported a position in CLB in Q2 2013 and held it in 14 quarters. The position peaked at $970K in Q3 2014. 174 funds tracked by Wall St. Rank hold CLB as of Q4 2021.
- Walleye Trading reported no remaining Core Laboratories position as of Q4 2021 after selling out during the quarter.
- Walleye Trading sold 5,424 Core Laboratories shares in Q4 2021, an estimated $151K.
- Walleye Trading first reported a position in Core Laboratories in Q2 2013 and held it in 14 quarters.
- Walleye Trading's Core Laboratories position peaked at $970K in Q3 2014.
- 174 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2021.
Based on Walleye Trading's 13F filing for Q4 2021, filed 14 Feb 2022.